IN BRIEF: Arix Bioscience eyes $19 million return from Harpoon sale
Arix Bioscience PLC - London-based venture capital firm investing in ‘breakthrough’ biotechnology companies - Expects $18.6 million net proceeds from its $680 million sale of...
Fri, 19/01/2024 - 11:29